Page last updated: 2024-11-07

lynestrenol and Cancer of Pituitary

lynestrenol has been researched along with Cancer of Pituitary in 2 studies

Lynestrenol: A synthetic progestational hormone used often in mixtures with estrogens as an oral contraceptive (CONTRACEPTIVES, ORAL).

Research Excerpts

ExcerptRelevanceReference
"To assess a possible inhibitory effect of progestins on PRL secretion, serum PRL and estradiol levels were determined in 13 women with hyperprolactinemia due to a pituitary microadenoma before and after 3 months of treatment with a potent progestin, lynestrenol."3.67In vivo effects of progestins on prolactin secretion. ( Clair, F; Fermanian, J; Maugis, E; Mauvais-Jarvis, P; Sitruk-Ware, R; Varin, C, 1985)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moult, PJ1
Dacie, JE1
Rees, LH1
Besser, GM1
Sitruk-Ware, R1
Varin, C1
Clair, F1
Maugis, E1
Fermanian, J1
Mauvais-Jarvis, P1

Other Studies

2 other studies available for lynestrenol and Cancer of Pituitary

ArticleYear
Oral contraception in patients with hyperprolactinaemia.
    British medical journal (Clinical research ed.), 1982, Mar-20, Volume: 284, Issue:6319

    Topics: Adult; Bromocriptine; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Lynestrenol; Pituitar

1982
In vivo effects of progestins on prolactin secretion.
    The Journal of clinical endocrinology and metabolism, 1985, Volume: 60, Issue:3

    Topics: Adenoma; Adult; Female; Humans; Lynestrenol; Middle Aged; Pituitary Neoplasms; Progestins; Prolactin

1985